Cargando…

Enhanced efficacy of IL-15-based ALT-803 superagonist complex in combination with immune checkpoint inhibitors in hematologic and metastatic mouse tumor models

Detalles Bibliográficos
Autores principales: Xu, Wenxin, Marcus, Warren D, Rhode, Peter R, Wong, Hing C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288421/
http://dx.doi.org/10.1186/2051-1426-2-S3-P121
_version_ 1782351969370767360
author Xu, Wenxin
Marcus, Warren D
Rhode, Peter R
Wong, Hing C
author_facet Xu, Wenxin
Marcus, Warren D
Rhode, Peter R
Wong, Hing C
author_sort Xu, Wenxin
collection PubMed
description
format Online
Article
Text
id pubmed-4288421
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42884212015-01-15 Enhanced efficacy of IL-15-based ALT-803 superagonist complex in combination with immune checkpoint inhibitors in hematologic and metastatic mouse tumor models Xu, Wenxin Marcus, Warren D Rhode, Peter R Wong, Hing C J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4288421/ http://dx.doi.org/10.1186/2051-1426-2-S3-P121 Text en Copyright © 2014 Xu et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Xu, Wenxin
Marcus, Warren D
Rhode, Peter R
Wong, Hing C
Enhanced efficacy of IL-15-based ALT-803 superagonist complex in combination with immune checkpoint inhibitors in hematologic and metastatic mouse tumor models
title Enhanced efficacy of IL-15-based ALT-803 superagonist complex in combination with immune checkpoint inhibitors in hematologic and metastatic mouse tumor models
title_full Enhanced efficacy of IL-15-based ALT-803 superagonist complex in combination with immune checkpoint inhibitors in hematologic and metastatic mouse tumor models
title_fullStr Enhanced efficacy of IL-15-based ALT-803 superagonist complex in combination with immune checkpoint inhibitors in hematologic and metastatic mouse tumor models
title_full_unstemmed Enhanced efficacy of IL-15-based ALT-803 superagonist complex in combination with immune checkpoint inhibitors in hematologic and metastatic mouse tumor models
title_short Enhanced efficacy of IL-15-based ALT-803 superagonist complex in combination with immune checkpoint inhibitors in hematologic and metastatic mouse tumor models
title_sort enhanced efficacy of il-15-based alt-803 superagonist complex in combination with immune checkpoint inhibitors in hematologic and metastatic mouse tumor models
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288421/
http://dx.doi.org/10.1186/2051-1426-2-S3-P121
work_keys_str_mv AT xuwenxin enhancedefficacyofil15basedalt803superagonistcomplexincombinationwithimmunecheckpointinhibitorsinhematologicandmetastaticmousetumormodels
AT marcuswarrend enhancedefficacyofil15basedalt803superagonistcomplexincombinationwithimmunecheckpointinhibitorsinhematologicandmetastaticmousetumormodels
AT rhodepeterr enhancedefficacyofil15basedalt803superagonistcomplexincombinationwithimmunecheckpointinhibitorsinhematologicandmetastaticmousetumormodels
AT wonghingc enhancedefficacyofil15basedalt803superagonistcomplexincombinationwithimmunecheckpointinhibitorsinhematologicandmetastaticmousetumormodels